Peptides are everywhere in sport and injury rehab, but popularity doesnt equal proof., , Substances like BPC 157 are often marketed as promising, yet the research has major flaws and lacks Cagrilintide: What It Is and How It's Being Studied for Weight Loss Latest science on Cagrilintide from Novo Nordisk In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options